EN
中文
EN
Who We Are
Newsroom
Innovation
Products
Investor Relations
Careers
Contact Us
Information Disclosure
Home
>
Investor Relations
>
Information Disclosure
H Share
2022 AGM CIRCULAR
Notification Letter and Request Form to Non-registered Shareholders
Form of Proxy for use at the 2023 First Class Meeting of H shareholders
Form of Proxy for use at the 2022 Annual General Meeting
NOTICE OF 2022 ANNUAL GENERAL MEETING
NOTICE OF 2023 FIRST CLASS MEETING OF H SHAREHOLDERS
INDICATIVE ANNOUNCEMENT ON THE POSTPONEMENT OF RE-ELECTION OF THE BOARD OF DIRECTORS AND THE BOARD OF SUPERVISORS
SUPPLEMENTAL ANNOUNCEMENT PROPOSED AMENDMENTS TO THE ARTICLES OF ASSOCIATION AND RELEVANT RULES OF PROCEDURES
VOLUNTARY ANNOUNCEMENT REGISTRATION OF RECOMBINANT COVID-19 VACCINE (ADENOVIRUS TYPE 5 VECTOR) AS A PHARMACEUTICAL PRODUCT IN HONG KONG
Monthly Return of Equity Issuer on Movements in Securities
1
16
17
18
19
20
52
津公网安备12011602300399
